Sun Pharma Withdraws 11 Eye Medicines

Times of India · top

Sun Pharma has decided to withdraw 11 of its eye drop medicines from the US market. The company cited concerns regarding manufacturing practices at its Halol facility in Gujarat. This voluntary withdrawal follows an inspection by the USFDA. The move aims to address quality issues and ensure compliance with regulatory standards, potentially impacting the company's market presence in the US.